Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 369Ovarian Neoplasms 99Lung Neoplasms 99Neoplasms 85Small Cell Lung Carcinoma 71Breast Neoplasms 59Neoplasm Metastasis 50Triple Negative Breast Neoplasms 46Parkinson Disease 4, Autosomal Dominant Lewy Body 41Fallopian Tube Neoplasms 38Squamous Cell Carcinoma of Head and Neck 33Carcinoma 31Endometrial Neoplasms 30Uterine Cervical Neoplasms 28Colorectal Neoplasms 25Carcinoma, Ovarian Epithelial 23Head and Neck Neoplasms 19Carcinoma, Transitional Cell 18Urinary Bladder Neoplasms 17Advanced Solid Tumors 17Recurrence 15Melanoma 14Stomach Neoplasms 13Peritoneal Neoplasms 13Pancreatic Neoplasms 13Adenocarcinoma 11Lung Diseases 9Glioblastoma 9Carcinoma, Squamous Cell 9Thoracic Neoplasms 8

Interventions

tusamitamab ravtansine 2Ramucirumab 2Docetaxel 2telomerase reverse transcriptase p572Y, human 1pembrolizumab 1necitumumab 1Paclitaxel 1LY3023414 1Gemcitabine 1Erlotinib Hydrochloride 1Data Collection 1Carboplatin 1Bevacizumab 11-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Non-small Cell Lung Cancer Metastatic × Carboplatin × Clear all
NCT01966003 2017-10-19

Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer

Amgen

Phase 3 Completed
642 enrolled 17 charts
Thoracic

Non-small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡